Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Sep 29, 2020 1:31pm
65 Views
Post# 31635800

RE:RE:RE:RE:RE:Insiders are buying

RE:RE:RE:RE:RE:Insiders are buying
MrMugsy wrote: You don't know anyting about Medison except that it paid a dividend.
You liked the dividend - that's a fact.
I like the dividend too.

At the time, I looked at the data Meir provided as he only showed his last 10 year of operation.
My question was simple ... where are your first 10 years?
From what I recall, it took Meir 10 years to get to $50M in sales.
It's not something he wanted to reveal but there was no hiding it ...once he showed us the last 10 years.

Fact is, it took him 20 yeasr to build his company and it mimicked Paladin's growth curve to a "T."  It is mimicking Knight's growth curve as well - thus far.

So ... to allow Meir the opportunity to risk our cash hoard on the latest and greatest technologies would have gone completely against the things this company values. Shareholders were not going to vote for Meir (as I predicted) because they put their trust in Goodman and allowing Goodman to do it one more time.

I've already explained that Meir was never going to win that battle.
I've already said he'd never create a Canadian arm on his own - like he threatened.
There was no way for him to be able to move as quickly as he wanted, without taking major gambles and he's not doing that with his money. 

Investors here were simply not interested in risk. 

Not sure why Meir still exists as a talking point.  His dream of using our cash to gamble on the future was simply NEVER going to happen.




Stop altering the facts. Medison was the BEST asset we owned and appreciated handsomely, thanks to Meir. It was your brilliant CEO's best investment so far, by a mile. And 'gamble on the future with our cash'. Current management has done just that. What would you call buying some company in one of the most economically, monetary and fiscally risky regions of the world? 

You need to stop comparing this company to PLB, just stop! Enough already with your spin and stupid excuses for the underperformance here. PLB was started as a small business, a tiny business, a start-up with next to no cash and given drugs to sell by the parent to get the ball rolling. Knight had hundreds of milions in it's back pocket from inception, in other words a 15 year head start on PLB. Just stop, your posts spinning this same bulllshittt is nauseating. You aren't fooling anyone here. 

Reality is Meir was 1-2 years too early in his battle. He launched it when the company was in the high $7.00 range and most shareholders were willing to be patient. If this would have launched right now, at a SIX year low in share price after spending 1/2 a billion $$$, the support would be greater and not a clear cut win for management. Face it, most of the issues he was against have now come to pass whether you care to admit it or not.
<< Previous
Bullboard Posts
Next >>